Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE3154.75-5.2 (-0.16 %)

PREV CLOSE ( ) 3159.95

OPEN PRICE ( ) 3180.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1590

TODAY'S LOW / HIGH ( )3120.85 3217.10

52 WK LOW / HIGH ( )1924.3 3515.95

NSE3144.20-18.2 (-0.58 %)

PREV CLOSE( ) 3162.40

OPEN PRICE ( ) 3175.00

BID PRICE (QTY) 3144.20 (87)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 115563

TODAY'S LOW / HIGH( ) 3120.40 3220.00

52 WK LOW / HIGH ( )1921 3515.7

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

9743.7

9494.2

10107.7

8146.5

Total Expenditure

6411.8

6575

6890.6

5841.1

PBIDT (Excl OI)

3331.9

2919.2

3217.1

2305.4

Other Income

406.8

350.7

345.4

356.4

Operating Profit

3738.7

3269.9

3562.5

2661.8

Interest

5.8

0.9

2.7

3.7

Exceptional Items

46.9

PBDT

3732.9

3269

3606.7

2658.1

Depreciation

147.2

188

168.6

164.1

Profit Before Tax

3585.7

3081

3438.1

2494

Tax

957

782.2

913.1

670.7

Provisions and contingencies

Profit After Tax

2628.7

2298.8

2525

1823.3

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

2628.7

2298.8

2525

1823.3

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

2628.7

2298.8

2525

1823.3

Equity Capital

1694.1

Face Value (IN RS)

Reserves

Calculated EPS

15.51

13.56

14.90

10.76

Calculated EPS (Annualised)

62.06

54.27

59.61

43.05

No of Public Share Holdings

42351510

% of Public Share Holdings

PBIDTM% (Excl OI)

34.19

30.74

31.82

28.29

PBIDTM%

38.37

34.44

35.24

32.67

PBDTM%

38.31

34.43

35.68

32.62

PBTM%

36.80

32.45

34.01

30.61

PATM%

26.97

24.21

24.98

22.38

Notes

Risk Disclosures on Derivatives

Quarterly Results

GLAXOSMITHKLINE PHARMACEUTICALS LTD.